01 1Cadila Pharmaceuticals
01 1ETHAMBUTOL HYDROCHLORIDE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2016-01-12
Pay. Date : 2015-01-15
DMF Number : 11171
Submission : 1994-10-31
Status : Active
Type : II
20
Cadila Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ETHAMBUTOL HYDROCHLORIDE USP, with a corresponding US DMF Number 11171.
Remarkably, this DMF maintains an Active status since its submission on October 31, 1994, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 12, 2016, and payment made on January 15, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II
